Approval · Notice of Compliance 5813 · 1994
ORGARAN: Notice of Compliance 5813
Issued October 5, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5813
- Date
- October 5, 1994
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anti-thrombotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | 02129043 | Marketed |
Medicinal ingredients
- DANAPAROID SODIUM 1,250 UNIT per ML